Molecular characterization of mutations in patients with benign and aggressive recurrent respiratory papillomatosis: A preliminary study

Annals of Otology, Rhinology and Laryngology

Volumn 113, Issue 3 I, 2004, Pages 180-186

  Pou, Anna M ^a,b   Weems, Justin ^a,b   Nason, Robert ^a,b   Deskin, Ronald W ^a,b   Payne, Deborah A ^a,b  

^a University of Texas Medical Branch ^*

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Aggressive disease course; Genetic sequence; Human papillomavirus; Polymorphism; Variant

Indexed keywords

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; INFANT; LARYNX; LUNG INFECTION; MALE; PAPILLOMATOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; VIRUS ISOLATION; VIRUS STRAIN; WART VIRUS;

EID: 1542515002     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940411300302     Document Type: Article

References (20)

1. Derkay CS. Recurrent respiratory papillomatosis. Laryngoscope 2001;111:57-69.
2. Derkay CS. Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg 1995;121:1386-91.
3. Bishai D, Kashima H, Shah K. The cost of juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2000;126:935-9.
4. Armstrong LR, Derkay CS, Reeves WC. Initial results from the National Registry for Juvenile-Onset Recurrent Respiratory Papillomatosis. RRP Task Force. Arch Otolaryngol Head Neck Surg 1999;125:743-8.
5. Doyle DJ, Gianoli GJ, Espinola T, Miller RH. Recurrent respiratory papillomatosis: juvenile and adult forms. Laryngoscope 1994;104:523-7.
6. Kimberlin DW. Pharmacotherapy of recurrent respiratory papillomatosis. Expert Opin Pharmacother 2002;3:1091-9.
7. Gabbott M, Cossart YE, Kan A, Konopka M, Chan R, Rose BR. Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J Clin Microbiol 1997;35:3098-103.
8. Penaloza-Plascencia M, Montoya-Fuentes H, Flores-Martinez SE, Fierro-Velasco FJ, Penaloza-Gonzales JM, Sanchez-Corona J. Molecular identification of 7 human papillomavirus types in recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2000;126:1119-23.
9. May M, Dong XP, Beyer-Finkler E, Stubenrauch F, Fuchs PG, Pfister H. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J 1994;13:1460-6.
10. Rose BE, Thompson CH, Zhang J, et al. Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. Gynecol Oncol 1997;66:282-9.
11. Byrne JC, Tsao MS, Fraser RS, Howley PM. Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. N Engl J Med 1987;317:873-8.
12. DiLorenzo TP, Tamsen A, Abramson AL, Steinberg BM. Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. J Gen Virol 1992;73:423-8.
13. Kitasato H, Delius H, zur Hausen H, Sorger K, Rosl F, de Villiers EM. Sequence rearrangements in the upstream regulatory region of human papillomavirus type 6: are these involved in malignant transition? J Gen Virol 1994;75:1157-62.
14. Pou AM, Rimell FL, Jordan JA, et al. Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis. Ann Otol Rhinol Laryngol 1995; 104:758-62.
15. Rimell FL, Shoemaker DL, Pou AM, Jordan JA, Post JC, Ehrlich GD. Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors. Laryngoscope 1997;107:915-8.
16. Stern Y, Hurtubise PE, Cotton RT. Significance of DNA ploidy and cell proliferation in juvenile respiratory papillomatosis. Ann Otol Rhinol Laryngol 1998;107:815-9.
17. Rady PL, Schnadig VJ, Weiss RL, Hughes TK, Tyring SK. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope 1998;108:735-40.
18. de Roda Husman AM, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
19. Chan SY, Delius H, Halpern AL, Bernard HU. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 1995;69:3074-83.
20. Heinzel PA, Chan SY, Ho L, et al. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol 1995;33:1746-54.